Isolated peptides which complex with hla-cw*16 molecules, and uses thereof
CA 2264563 A1 · Owner: Ludwig Institute For Cancer Research · Inventors: Deplaen, Etienne; Boon-Falleur, Thierry; Van Der Bruggen, Pierre
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention involves the identification of peptides which complex with HLA-Cw*16 molecules and which may then provoke lysis, of the cells to which they bind by cytolytic T cells. Diagnostic and therapeutic uses are described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 27, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 27, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 27, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.